M. Fennen

Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction

C. Hartmann, C. Cromme, T. Pap, 2016, Science Translational Medicine.

Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice

J. Bertrand, T. Pap, K. Redlich, 2015, Nature Medicine.

A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis

D. Foell, T. Pap, G. Varga, 2021, Scientific Reports.

Deletion of activin A in mesenchymal but not myeloid cells ameliorates disease severity in experimental arthritis

T. Pap, P. Paruzel, C. Wehmeyer, 2022, Annals of the Rheumatic Diseases.

Components in Plasma-Derived Factor VIII, But Not in Recombinant Factor VIII Downregulate Anti-Inflammatory Surface Marker CD163 in Human Macrophages through Release of CXCL4 (Platelet Factor 4)

A. Fender, R. Kelsch, M. Brodde, 2017, Transfusion Medicine and Hemotherapy.

Smad-dependent mechanisms of inflammatory bone destruction

T. Pap, B. Dankbar, M. Fennen, 2016, Arthritis Research & Therapy.

Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction

C. Hartmann, C. Cromme, T. Pap, 2016, Science Translational Medicine.